For 11 years, Intercept has researched and developed a novel nuclear receptor (FXR). Find out how this science applies to liver and metabolic conditions.
http://www.interceptpharma.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
1.1 seconds
PERFECT PRIVACY, LLC
12808 Gr●●●●●●●●kwy West
Jack●●●●ille , FL, 32258
US
View this contact
PERFECT PRIVACY, LLC
12808 Gr●●●●●●●●kwy West
Jack●●●●ille , FL, 32258
US
View this contact
PERFECT PRIVACY, LLC
12808 Gr●●●●●●●●kwy West
Jack●●●●ille , FL, 32258
US
View this contact
BUY YOUR DOMAIN
21
YEARS
7
MONTHS
6
DAYS
REGISTER.COM, INC.
WHOIS : whois.register.com
REFERRED : http://www.register.com
PAGES IN
THIS WEBSITE
9
SSL
EXTERNAL LINKS
146
SITE IP
35.185.31.195
LOAD TIME
1.08 sec
SCORE
6.2
Intercept Pharmaceuticals | interceptpharma.com | interceptpharma.com Reviews
https://interceptpharma.com
For 11 years, Intercept has researched and developed a novel nuclear receptor (FXR). Find out how this science applies to liver and metabolic conditions.
Investors - Intercept Pharmaceuticals, Inc.
4:00 PM ET on Aug 14, 2015. Delayed at least 20 minutes. Aug 5, 2015. Intercept Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Business Update. Jul 29, 2015. Intercept to Report Second Quarter 2015 Financial Results on August 5 and Present at Upcoming Conferences. View all press releases. Recent Events and Presentations. Aug 11, 2015 at 10:55 AM ET. 2015 Wedbush PacGrow Healthcare Conference. Aug 5, 2015 at 4:30 PM ET. Second Quarter 2015 Financial Results and Conference Call.
interceptpharma.com
Glossary | Intercept Pharmaceuticals, Inc
https://interceptpharma.com/glossary
Investors & Media. Events & Presentations. Publications and Conference Materials. Learn about clinical trials that are currently recruiting. Phase 3 NASH Study. Phase 4 PBC Study. Phase 2 PSC Study. Phase 2 Biliary Atresia Study. At Intercept, our work is motivated by our desire to help patients and families who struggle with chronic liver diseases and need better treatment options. A chemical in the body that can be used to diagnose PBC. A condition in which the body attacks a part of itself.
Intercept Careers | Intercept Pharmaceuticals, Inc
https://interceptpharma.com/careers
Investors & Media. Events & Presentations. Publications and Conference Materials. Learn about clinical trials that are currently recruiting. Phase 3 NASH Study. Phase 4 PBC Study. Phase 2 PSC Study. Phase 2 Biliary Atresia Study. At Intercept, our work is motivated by our desire to help patients and families who struggle with chronic liver diseases and need better treatment options. A world of opportunity at Intercept Pharmaceuticals. Take a look at our current listings.
Living with PBC | Intercept Pharmaceuticals, Inc
https://interceptpharma.com/patient-resources/pbc-patient-stories
Investors & Media. Events & Presentations. Publications and Conference Materials. Learn about clinical trials that are currently recruiting. Phase 3 NASH Study. Phase 4 PBC Study. Phase 2 PSC Study. Phase 2 Biliary Atresia Study. At Intercept, our work is motivated by our desire to help patients and families who struggle with chronic liver diseases and need better treatment options. First-hand accounts from people who have primary biliary cholangitis (PBC). Ally, Cleveland, OH, diagnosed with PBC. 8220;O...
Partnering | Intercept Pharmaceuticals, Inc
https://interceptpharma.com/partnering
Investors & Media. Events & Presentations. Publications and Conference Materials. Learn about clinical trials that are currently recruiting. Phase 3 NASH Study. Phase 4 PBC Study. Phase 2 PSC Study. Phase 2 Biliary Atresia Study. At Intercept, our work is motivated by our desire to help patients and families who struggle with chronic liver diseases and need better treatment options. Out-licensing: INT-777 Intercept is evaluating out-licensing opportunities for this preclinical product candidate. PBC) and...
FXR | Intercept Pharmaceuticals, Inc
https://interceptpharma.com/development/fxr
Investors & Media. Events & Presentations. Publications and Conference Materials. Research & Development. Learn about clinical trials that are currently recruiting. Phase 3 NASH Study. Phase 4 PBC Study. Phase 2 PSC Study. Phase 2 Biliary Atresia Study. At Intercept, our work is motivated by our desire to help patients and families who struggle with chronic liver diseases and need better treatment options. FXR is a nuclear receptor expressed in the liver, intestine, kidney, and adipose tissue. A new mech...
TOTAL PAGES IN THIS WEBSITE
9
Analyst Coverage - Intercept Pharmaceuticals, Inc.
http://ir.interceptpharma.com/analysts.cfm
Intercept Pharmaceuticals, Inc. is covered by the following analysts:. Bank of America Merrill Lynch. Jonathan Eckard, Ph.D. Goldman, Sachs and Co. Royal Bank of Canada. Jim Birchenough, M.D. 450 W 15th Street, Suite 505 New York, NY 10011 T: 844-782-ICPT F: 646-747-1001. 2016 Intercept Pharmaceuticals, Inc.
Quarterly Results - Intercept Pharmaceuticals, Inc.
http://ir.interceptpharma.com/results.cfm
Intercept Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Business Update. Third Quarter 2016 Financial Results and Conference Call. File is in Briefcase. Intercept Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update. Second Quarter 2016 Financial Results and Conference Call. Intercept Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Business Update. First Quarter 2016 Financial Results and Conference Call. Add file...
Historic Stock Lookup - Intercept Pharmaceuticals, Inc.
http://ir.interceptpharma.com/stocklookup.cfm
Adjusted historic prices for the week of October 31, 2016. Oct 31, 2016. Nov 1, 2016. Nov 2, 2016. Nov 3, 2016. Nov 4, 2016. The historical stock information provided is for informational purposes only and is not intended for trading purposes. The historical stock information is provided by Mergent, a third party service, and Intercept Pharmaceuticals, Inc. does not maintain or provide information directly to this service. Prices display split-adjusted cost basis per share on that date.
Annual Reports and Proxies - Intercept Pharmaceuticals, Inc.
http://ir.interceptpharma.com/annuals-proxies.cfm
Annual Reports and Proxies. Annual reports and proxies. Feb 29, 2016. File is in Briefcase. Mar 2, 2015. File is in Briefcase. Mar 14, 2014. File is in Briefcase. Apr 1, 2013. File is in Briefcase. Jun 20, 2016. File is in Briefcase. Oct 29, 2015. File is in Briefcase. Jun 23, 2014. File is in Briefcase. Apr 12, 2013. File is in Briefcase. Add file to Briefcase. Annual Reports and Proxies. 450 W 15th Street, Suite 505 New York, NY 10011 T: 844-782-ICPT F: 646-747-1001. 2016 Intercept Pharmaceuticals, Inc.
Stock Information - Intercept Pharmaceuticals, Inc.
http://ir.interceptpharma.com/stockquote.cfm
4:00 PM ET on Nov 4, 2016. Sign up for email alerts. The stock information provided is for informational purposes only and is not intended for trading purposes. The stock information is provided by eSignal, stock charts are provided by NASDAQ OMX, both third party services, and Intercept Pharmaceuticals, Inc. does not maintain or provide information directly to this service. Stock information is delayed approximately 20 minutes. 2016 Intercept Pharmaceuticals, Inc.
Committee Composition - Intercept Pharmaceuticals, Inc.
http://ir.interceptpharma.com/committees.cfm
Srinivas Akkaraju, M.D., Ph.D. Srinivas Akkaraju, M.D., Ph.D. Member of the Compensation Committee. Member of the Research and Development Committee. Luca Benatti, Ph.D. Luca Benatti, Ph.D. Member of the Nominating and Governance Committee. Chair of the Research and Development Committee. Member of the Audit Committee. Member of the Nominating and Governance Committee. Keith Gottesdiener, M.D. Keith Gottesdiener, M.D. Member of the Research and Development Committee. Mark Pruzanski, M.D.
Corporate Governance - Intercept Pharmaceuticals, Inc.
http://ir.interceptpharma.com/corporate-governance.cfm
File is in Briefcase. Nominating and Governance Committee Charter. File is in Briefcase. File is in Briefcase. Code of Conduct and Ethics. File is in Briefcase. File is in Briefcase. Add file to Briefcase. 450 W 15th Street, Suite 505 New York, NY 10011 T: 844-782-ICPT F: 646-747-1001. 2016 Intercept Pharmaceuticals, Inc.
Dosing | OCALIVA obeticholic acid for Healthcare Providers
https://www.ocalivahcp.com/dosing
Dosage and Administration for OCALIVA. The recommended starting dosage for OCALIVA is 5 mg orally once daily in adult patients who have not achieved an adequate biochemical response on an appropriate dosage of UDCA for ≥1 year or are intolerant to UDCA. If an adequate reduction in alkaline phosphatase and/or total bilirubin has not been achieved after 3 months, and the patient is tolerating OCALIVA, increase the dosage to 10 mg once daily. OCALIVA can be taken with or without food. Guidance for Treatment...
Koinfektionen Hepatitis/HIV – Hepatitis Akademie
http://hepatitis-akademie.de/koinfektionen-hepatitishiv
BAVENO VI: Portale Hypertension. Gerinnungsstörungen bei Leberkrankheiten (Hepato Update 2016). Vaskuläre Lebererkrankungen (Hepato Update 2015). Chronische Virushepatitis (Hepato Update 2013). Experteninterviews vom 50. EASL Kongress in Wien. Interviews von der AASLD-Jahrestagung 2014. Interviews von der EASL-Tagung 2014. Baraclude Hepatitis B Webinare. Hep-B im Dialog: EASL 2013. BAVENO VI: Portale Hypertension. Gerinnungsstörungen bei Leberkrankheiten (Hepato Update 2016). Hep-B im Dialog: EASL 2013.
TOTAL LINKS TO THIS WEBSITE
146
Untitled 1
For security reason every user activity is controlled and all public addresses are stored in our system.
Interceptor Waste Removal Services
Domestic and Commercial Services. No call out charges. Regular interceptor maintenance is vital. With decades of experience we have established ourselves as market leaders in servicing any type of interceptor. Over time, we have continually adapted and improved our technology and vehicles to offer the most complete service available. Hydro Cleansing lies within 10 miles of Central London and only 8 miles from the motorway networks giving us easy access to our entire customer base. At Your Service 24/...
Intercept PdM LLC
Skip to main navigation. Skip to first column. Skip to second column. Welcome to Intercept PdM, LLC! We are a manufacturer's representative and consulting firm, specializing in predictive maintenance and condition monitoring products and services. Operating out of Northeast Ohio, we offer products and support for motor testing, vibration analysis, laser alignment, infrared thermography, lubrication monitoring and asset basic care in Michigan, Ohio, Western Pennsylvania and West Virginia. Head over to our.
Home
Over 30 years experience. Licensed Pest Control Operator. Bonded and Insured. Call today. 818-992-8671. Botanical (green) products available. We protect your health and your home. Learn more about services you can benefit from. Hear customers talk about how Intercept Pest Management improved their home, business or property. Make a payment on time by paying online. Visa, Mastercard or bank account payments are accepted. Free quotes are available! Call now to find out how to be pest and worry free.
Intercept Pest Control | Rats, Mice, Ants, Cockroaches, Termites, Bird Control | NSW Australia
Utilising an Integrated Pest Management Approach for the Ultimate Protection of your Home or Business. Intercept Pest Control provide a holistic approach to your pest control needs from the time our professional pest managers step into your premises. Our pest managers comprehensively inspect your property and provide you with the following details:-. Frequency of inspection and service. Types of Chemicals to be used with MSDSs. Our Occupational Health and Safety Systems.
Intercept Pharmaceuticals | interceptpharma.com
Investors & Media. Events & Presentations. Publications and Conference Materials. Our mission is to build a healthier tomorrow for patients with progressive non-viral liver diseases. Ally is a mother, teacher, and motorcycle enthusiast living with liver disease. She is also our inspiration. Read our U.S. Prescribing Information. Click here for our Medication Guide. Learn about clinical trials that are currently recruiting. Find information about our recent press releases, events and presentations.
Intercept® Plans - Investment Exchange bringing together qualified investors with data driven business plans and financial models
To present to investors. Have a great idea for a Startup? Trying to write a Business Plan and find Investors? Intercept is a business planning and financial modeling tool for Startup, Investors, Educators, Communities, and Entrepreneurs. We guide you step by step through the entire process, allowing you to customize each section of your business plan and generate a financial model based around your Startup ideas. No one said you had to stand up your startup alone. The makers of Intercept (Deziner Softwar...
Intercept Poverty
With Wellbeing, Knowledge and Enterprise Programs. Inspiration, Models and Ideas for Enlightened Leaders. www.interceptpoverty.org. Monday, June 7, 2010. Ivan Grech says "show your heart and help Intercept Poverty". Because Intercept Poverty is small and independent, because it has specific links to supporting the work done in East Africa, by Maltese Women. Because of these factors, he was eager to involve himself and learn more about Intercept Poverty. Thank you Ivan, God Bless You! Thursday, September ...
Intercept Programs, Substance Abuse Treatment, Dui Counseling
INTERCEPTPROTECTION.COM
